- HOME>
- News>
- Fiscal 2006>
- Press Releases
July 20, 2006 |
Asahi Kasei Pharma Corporation
Asahi Kasei Medical Co., Ltd. |
Expansion of capacity for assembly of Planova™ filters
|
|
Asahi Kasei Medical will add a new assembly line for Planova™
virus removal filters, with a capacity of 20,000 m2/year.
Complementing an existing line of the same capacity, this will raise total
Planova™ filter assembly capacity to 40,000 m2/year.
Planova™ filters are used to remove viruses during the manufacture of
biotherapeutic drug products such as biopharmaceuticals and plasma derivatives.
Enabling high rates of virus removal and protein recovery, Planova™
filters are widely recognized for their robust performance in contributing to
the safety of biotherapeutics. Nearly 90% of sales are to customers in Europe
and the US.
With heightened standards throughout the world for the viral safety
of biotherapeutics and advances in the development of monoclonal antibodies
and other biopharmaceuticals, demand for Planova™ filters is growing briskly.
The new assembly capacity will enable Asahi Kasei Medical to meet this growing
demand. Asahi Kasei Medical is also advancing new product development to
meet emerging needs for quality and performance.
Outline of the new assembly line
Location: |
Nobeoka, Miyazaki, Japan |
Capacity: |
20,000 m2/year (raising total to 40,000 m2/year) |
Investment: |
Approx. ¥700 million |
Schedule: |
October 2006 groundbreaking, October 2007 start-up |
Sales forecast: |
¥8 billion for Planova™ filters in fiscal 2010 (double fiscal 2005 sales) |
Asahi Kasei Medical corporate profile
President: |
Yasuyuki Yoshida |
Establishment: |
July 1974 |
Paid-in capital: |
¥800 million |
Shareholding: |
100% by Asahi Kasei Pharma |
Head office: |
Tokyo, Japan |
Production facilities: |
|
|
Nobeoka - production of hollow-fiber dialyzer membrane,
production of hollow-fiber virus removal membrane, assembly of Planova™
virus removal filters
Oita - assembly of dialyzers and blood filters
China - assembly of dialyzers |
|
Employees: |
Approx. 1,700 (as of March 31, 2006) |
Fiscal 2005 sales: |
¥40.1 billion (year ended March 2006) |
Main products: |
|
|
Dialyzers, leukoreduction filters for transfusion,
blood purification products, Planova™ virus removal filters |
|
|
|
|
Back to press release list

page top